Innovative Postbiotics Verb Biotics recently launched Keystone Postbiotic, demonstrating their capability to develop foundational gut microbiome solutions, which could appeal to probiotics and supplement brands seeking scientifically backed ingredients.

Strategic Collaborations The company's partnership with Evogene to develop probiotic strains producing microbial metabolites highlights their focus on precision microbiome health, presenting opportunities to collaborate with brands investing in innovative, targeted functional ingredients.

Expanding Portfolio Acquiring YSOPIA Bioscience's strain library and IP assets positions Verb Biotics to rapidly diversify their microbiome ingredient offerings, enabling sales teams to target a broader range of food, beverage, and supplement manufacturers.

Recent Funding & Growth With a $30M Series A funding round secured in 2021, Verb Biotics has significant capital to support research, product development, and expansion efforts, making them a strong partner for companies looking for innovative microbiome solutions.

Focus in a Growing Market Operating within the rapidly expanding microbiome health industry, Verb Biotics offers scalable ingredients that cater to the increasing demand for scientifically supported health solutions, ideal for market segments emphasizing gut health and personalized nutrition.